AMAG Pharmaceuticals Appoints VP

Nancy Griffith, Ph.D., has been appointed vice president, scientific communications and medical operations, AMAG Pharmaceuticals, Inc. Dr. Griffith reports to Brian Robinson, M.D., senior vice president, medical affairs, and will be responsible for the creation and implementation of AMAG’s medical communications and publication strategies.

"As AMAG continues to invest in development-stage assets such as AMAG-423 and ciraparantag, it is increasingly important to effectively communicate and publish the clinical data supporting these therapies," said Dr. Robinson. "Dr. Griffith brings the leadership and expertise necessary to develop robust medical communications and publication strategies, adding value to our strategic medical affairs objectives."

Dr. Griffith brings more than 20 years of publications and communications experience from both large and small pharmaceutical and biotechnology companies. Most recently she served as vice president, medical operations and communications at Wave Life Sciences where she established the medical affairs function to support pipeline growth, including the development and execution of medical communications, medical publications, medical information, and scientific writing for the company’s portfolio.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.